All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

16

Reset

16 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SerplulimabHLX10, HLX43Phase 325 trials

    Shanghai Henlius Biotech · Non Small Cell Lung Cancer, Carcinoma, Hepatocellular, SCLC, Extensive Stage

  • HLX07Phase 34 trials

    Shanghai Henlius Biotech · Colon Cancer Adenocarcinoma, Squamous NSCLC, Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

  • HLX22Phase 34 trials

    Shanghai Henlius Biotech · HER2 + Breast Cancer, HER2-low Hormone Receptor Positive Breast Cancer, Gastroesophageal-junction Cancer

  • EU-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • HLX87Phase 32 trials

    Shanghai Henlius Biotech · HER2 + Breast Cancer

  • US-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • HLX04-OPhase 31 trial

    Shanghai Henlius Biotech · Age Related Macular Degeneration

  • HLX11Phase 31 trial

    Shanghai Henlius Biotech · Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer

  • HLX13Phase 31 trial

    Shanghai Henlius Biotech · Hepatocellular Carcinoma (HCC)

  • HLX15Phase 31 trial

    Shanghai Henlius Biotech · Newly Diagnosed Multiple Myeloma

  • HLX17Phase 31 trial

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer

  • HX22Phase 31 trial

    Shanghai Henlius Biotech · HER2 + Breast Cancer

  • HLX01Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HLX26Phase 21 trial

    Shanghai Henlius Biotech · NSCLC Stage IV

  • HLX53Phase 21 trial

    Shanghai Henlius Biotech · Carcinoma, Hepatocellular

  • HLX79Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.